Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg Formulations
Status:
Completed
Trial end date:
2016-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the bioavailability of a generic product of amlodipine
with that of a reference product when administered to healthy volunteers under fasting
conditions. The test product name is BF-Amlodipine Tablet 10mg manufactured by Bright Future
Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited, and the
reference product is Norvasc Tablet 10mg. The plasma pharmacokinetic data of amlodipine
obtained from two formulations will be used to access the interchangeability of the products